SEC Form D · filed July 10, 2018
Revolution Medicines, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (20)
Anne-Sophie Davreux · Senningerberg, LuxembourgDirectorTodd Owens · Seattle, WADirectorDavid D. Morse · New York, NYDirectorDean D. Winick · New York, NYDirectorMatthew N. Bird · New York, NYDirectorGreg Gottesman · Seattle, WAExecDavid D. Morse · New York, NYExec · DirectorBrien P. Smith · Dallas, TXDirectorJames B. Saad · Loxley, ALExecJohn C. Atwater · San Francisco, CADirectorSteven A. Gerstung · San Francisco, CADirectorScott G. Douglass · San Francisco, CADirectorDaniel H. James · San Francisco, CADirectorJon W. Brayshaw · San Francisco, CADirectorDale Jones · Argyle, TXExec · DirectorJaret Walker · Denton, TXExecHenry Ellenbogen · Chevy Chase, MDDirectorJen Thomson · Grand Cayman, Cayman IslandsExecLuan A. Wilfong · Redwood City, CAExecRyan A. Martins · Redwood City, CAExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗